10 dergi
Q1 2024
Targeted Oncology
Springer Paris France
Oncology
Q1
Pharmacology
Q1
Cancer Research
Q2
1,645
SJR
63
H-Index
3,26
Atıf/Yayın
Q3 2024
Therapies
Elsevier Masson s.r.l. France
Pharmacology
Q3
0,432
SJR
44
H-Index
1,13
Atıf/Yayın
Q3 2024
Pharmacien Clinicien
Elsevier Masson s.r.l. France
Pharmacology
Q3
0,218
SJR
10
H-Index
0,21
Atıf/Yayın
Q4 2024
Journal de Pharmacie Clinique
John Libbey Eurotext France
Pharmacology
Q4
0,132
SJR
16
H-Index
0,17
Atıf/Yayın
- 2010
Antibiotiques
Masson Publishing France
Infectious Diseases
Pharmacology
medical
7
H-Index
0,17
Atıf/Yayın
Q3 2024
Prescrire International
Association Mieux Prescrire France
Pharmacology
Q3
Pharmacology
Q4
0,203
SJR
14
H-Index
0,13
Atıf/Yayın
Q4 2024
Actualites Pharmaceutiques
Elsevier Masson s.r.l. France
Pharmacology
Q4
Pharmacology
Q4
0,130
SJR
7
H-Index
0,08
Atıf/Yayın
Q4 2020
Journal des Anti-Infectieux
Elsevier Masson s.r.l. France
Infectious Diseases
Q4
Pharmacology
Q4
0,133
SJR
6
H-Index
Q4 2022
Pharmacien Hospitalier et Clinicien
Elsevier Masson s.r.l. France
Pharmacology
Q4
0,124
SJR
Q4 2013
International Journal of Essential Oil Therapeutics
Essential Oil Resource Consultants France
Complementary and Alternative Medicine
Q4
Pharmaceutical Science
Q4
Pharmacology
Q4
0,117
SJR
15
H-Index